New York Life Investment Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,879
| Closed | -$629K | – | 824 |
|
|
2024
Q3 | $629K | Sell |
1,879
-866
| -32% | -$290K | 0.01% | 791 |
|
|
2024
Q2 | $750K | Sell |
2,745
-55
| -2% | -$15K | 0.01% | 743 |
|
|
2024
Q1 | $968K | Sell |
2,800
-107
| -4% | -$37K | 0.01% | 680 |
|
|
2023
Q4 | $939K | Sell |
2,907
-18
| -0.6% | -$5.81K | 0.01% | 674 |
|
|
2023
Q3 | $1.05M | Sell |
2,925
-44
| -1% | -$15.8K | 0.01% | 619 |
|
|
2023
Q2 | $1.13M | Sell |
2,969
-151
| -5% | -$57.2K | 0.01% | 587 |
|
|
2023
Q1 | $1.49M | Buy |
3,120
+134
| +4% | +$64.2K | 0.02% | 561 |
|
|
2022
Q4 | $1.26M | Sell |
2,986
-83
| -3% | -$34.9K | 0.01% | 596 |
|
|
2022
Q3 | $1.28M | Sell |
3,069
-22
| -0.7% | -$9.19K | 0.02% | 584 |
|
|
2022
Q2 | $1.53M | Buy |
+3,091
| New | +$1.53M | 0.02% | 557 |
|